Exercise for Type 2 Diabetes
(RESIST Trial)

Recruiting in Palo Alto (17 mi)

Overseen byLauren M Sparks, PhD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Translational Research Institute for Metabolism and Diabetes, Florida

No Placebo Group

Approved in 1 Jurisdiction

Trial Summary

What is the purpose of this trial?The purpose of this study is to collect data to help researchers identify factors that prevent certain individuals from receiving the beneficial effects of exercise.

Eligibility Criteria

This trial is for adults aged 30-65 with Type 2 Diabetes, who are not currently exercising regularly. Participants can be on certain diabetes medications like metformin but must stop them during the study. They should have an HbA1c level that reflects moderate blood sugar control and be willing to exercise daily for the study period.

Inclusion Criteria

My HbA1c level is between 6.0% and 8.5%, or it's 8.5% or below if I'm on diabetes medication.

I am willing to stop my diabetes medication during the study.

My latest HbA1c level is between 5.7% and 8.8%, or below 8.9% if I'm on diabetes medication.

+7 more

Participant Groups

The trial is studying how exercise affects individuals with Type 2 Diabetes. Researchers want to understand why some people don't get the usual benefits from physical activity. Participants will engage in a prescribed exercise routine throughout the study.

2Treatment groups

Experimental Treatment

Active Control

Group I: ExerciseExperimental Treatment1 Intervention

10 weeks of aerobic exercise

Group II: Active ControlActive Control1 Intervention

Young athletes as a trained control